Key facts
- Imdetek’s last known valuation is $97.4M (Feb 2023).
- It has raised $14.7M; the latest was Later Stage VC in Apr 2025.
- Notable investors include CAS Star, Shaanxi Financial Asset Management, China National Nuclear, China National High-tech Industry Investment, Beijing Sunrise AXA Capital Management — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Imdetek
- ·The full record, as it builds
Funding rounds
No funding rounds for Imdetek are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Imdetek
Manufacturer of radiation detection material and device designed for safety inspection. The company provides CdZnTe radiation detectors, probes and radiation imaging system, supporting related business in safety inspection and industrial testing, nuclear medicine and clinical medicine, nuclear safety monitoring and astronomical observation and other fields, providing advanced radiation detector for industrial users.
- Sector
- Information Technology
- HQ
- Xianyang, China
- Founded
- 2012
- Employees
- 58
- Website
- imdetek.com/
- Ownership
- Privately Held (backing)
Imdetek doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Imdetek shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Imdetek in its N-PORT filings yet. We sweep new filings monthly.